text:
V i r g i n i a
C o m m o n w e a l t h SPR I N G
U n i v e r s i t y
2 013
Expanding Massey's Reach: Clinical Trials Open in South Hill INSIDE:
IMMUNOTHERAPY Unlocking New Ways to Fight Cancer Page 2 Massey's New Look 1
Life and Love After Cancer 8
Minority Participation in Clinical Trials 11
Campaign Update 12
Contents S P R I N G
2 013
Advance is published by VCU Massey Cancer Center, Office of Development and External Relations.
E ditor
Julie Dillon A S S I S T A N T E ditor
Matthew Lovisa DESIGN
12 16
Alaina Farrish Jenny Owen John Wallace PHOTOGRAPHY
David Hunter Hale Fran Householder VCU Creative Services John Wallace CONTACTS
To contact the editor, subscribe to Momentum, our monthly e-newsletter, or for general questions about Massey, e-mail firstname.lastname@example.com. To make contributions or inquire about ways to give, call (804) 828-1450 or visit www.massey.vcu.edu/givenow For cancer-related inquiries and free literature searches, contact our Patient Resource Libraries at (804) 828-8709. To make an appointment, call (804) 828-5116 or (877) 4-MASSEY.
1 Meet David Mainella Executive Director of Development and External Relations
2 Immunotherapy COVER STORY unlocking new ways to fight cancer
5 Sparks of Discovery funding and other research achievements
8 Centerpieces 1 0 Cancer Prevention and Control the latest Massey news
12 Investments in Progress 1 Commonwealth 4 Around the 16 Special Events notable gifts
Richmond Christmas Gala; Capitol Square Basketball Classic; Teaming Up With the YMCA to Support HDL, Inc. Massey Challenge; Women & Wellness; VCU Women's Basketball Pink Out; Black & Blue Classic Supports Massey; Live Local, Give Local
O N T H E C O V E R : The Community Memorial Healthcenter (CMH) oncology team,
led by Tzann Fang, MD; photo by Allen Jones See page 14
dvance is a publication for patients, friends, staff and supporters of VCU Massey Cancer Center, an internationally recognized center of research excellence. As a National Cancer Institute-designated Cancer Center, Massey is dedicated to saving and improving lives of those affected by cancer through innovative research and compassionate care.
Faculty Spotlight Meet David Mainella Executive Director of Development and External Relations
CU Massey Cancer Center gained a new member of its leadership team on February 11, when David Mainella Executive Director of Development and External Relations joined Massey. Mainella came to Massey from Duke Cancer Institute where he served as Deputy Director of D evelopment, overseeing a robust development program and providing leadership in streamlining giving strategies, developing innovative stewardship mechanisms and planning for a large scale campaign, all while maintaining a proven track record of fundraising success. Previously, David held development leadership positions at North Carolina State Engineering Foundation, Duke University Law School and the Krieger School of Arts & Sciences at Johns Hopkins University. "David's background has armed him with a valuable range of perspectives and experience that I am confident will be of enormous benefit to our development team, our advancement colleagues across the university, our Advisory Board and their collective effort in fulfilling the ambitious goals identified in the Research for Life Campaign," says Gordon D. Ginder, MD, director.
support that is really quite unique. With the dedicated and engaged Advisory Board, Massey Alliance and the growing momentum of the Research for Life Campaign, I saw the opportunity to take the fundraising program to a different level. Massey is a special place and I knew I wanted to be a part of it during my first visit.
One-on-One with David Mainella
I believe this is one of the reasons that developing our donors and advocates in all areas of the state is crucial. The Greater Richmond region has been incredibly supportive and we need to showcase the reach that Massey has
What drew you to VCU Massey Cancer Center?
I was drawn to Massey because it has such a strong tradition of philanthropic
What do you see as the biggest challenges and opportunities in reaching our $100 million Research for Life Campaign goal?
We have a great opportunity to continue building support for Massey in all areas of the state. It's the natural progression that will follow the increased research activity and clinical care that is happening throughout the Commonwealth. We also have a lot of potential to develop our relationships with grateful patients and their families. Our challenge will be to show how the priorities in the Research for Life Campaign are impacting patients now. Research is a long term investment, but our patients benefit from that investment every day. What are the key factors in continuing the growth of Massey's fundraising efforts during such challenging economic times?
David Mainella attained through our Statewide Clinical Research Affiliation Network and the unique clinical partnerships we are creating. What inspires you?
I'm inspired by the passion and dedication of Team Massey. I've never seen such a dedicated and supportive group of advocates and supporters. I know that by working together we can continue to make a difference in the lives of cancer patients and their families.
Massey Has a New Look!
s part of VCU's new university-wide branding initiative, VCU Massey Cancer Center is pleased to introduce a new logo. The new identity mark incorporates the updated Virginia Commonwealth University seal, as well as Massey's iconic "sunburst." "This new logo for Massey strengthens our cohesion with the university brand while maintaining the unique identity we have cultivated," says Jenny Owen, director of communications and public relations for Massey. "We are excited to embrace VCU's updated look and launch this new logo for Massey."
Spring 2013 • 1
Immunotherapy: Unlocking New Ways to Fight Cancer
earning of a cancer diagnosis has commonly brought with it not only fears for one's health and one's life, but the knowledge that the path to successful treatment was by no means easy or risk free. Most chemotherapy and radiation treatments come at a high expense to the patient's body—harming healthy cells right along with malicious cancer cells and putting patients at risk for other cancers or even other disease or health problems. While in the best circumstances the end result is permanent elimination of cancer, in too many instances a few cancer cells survive and lead to relapse. Immunotherapy offers the potential to allow the body to kill the remaining resistant tumor cells. "The concept of using the body's immune system to attack cancer has been around for many years, but attempts to show its effectiveness in treatment were hampered by a lack
of sufficient understanding of the complexities of the immune system," says Gordon D. Ginder, MD, director of VCU Massey Cancer Center. "Recent advances in the basic understanding of how immune cells recognize cancer cells and how to overcome mechanisms that block their ability to kill cancer cells have opened a whole new chapter in immunotherapy." New findings regarding the immune system have brought optimism about potentially less toxic, less invasive and more successful treatments—the essence of which already exists within the patient's own body. This line of research is called biological therapy or immunotherapy. Immunotherapy is defined by the National Cancer Institute as "treatment to boost or restore the ability of the immune system to fight cancer, infections and other diseases." It can also be used to improve outcomes while lessening side effects of other treatments.
The Body's Immune System
our immune system includes your spleen, lymph nodes, tonsils, bone marrow, and white blood cells. These all help protect you from getting infections and diseases. When your immune system works the way it should, it can tell the difference between "good" cells that keep you healthy and "bad" cells that make you sick. But sometimes this doesn't happen. Doctors are doing research to learn why some immune systems don't fight off diseases like cancer. White blood cells are an important part of your immune system. When doctors or nurses talk about white blood cells, he or she may use words like: • Monocytes (MON-o-cites) are types of white blood cells.
Researchers studying immunotherapy as it relates to cancer are exploring how the body's immune system works to stop or slow the growth of cancer cells, destroy cancer cells and/or keep cancer cells from spreading. The better they understand how the immune system is supposed to work, the better they can improve or treat malfunctions in the system that allow cancer to grow. "Basically, immunotherapy uses the capabilities that already exist in the human body's and makes them more effective at fighting cancer cells," says Ginder. "This line of research offers great potential to improve cancer treatments while decreasing unwanted side effects. As such, it fits squarely with the goal of modern cancer therapy, which is find to find new ways to eliminate cancer more effectively and simultaneously offer better quality of life." At VCU Massey Cancer Center, immunotherapy has gained attention and funding across several research programs, including the Developmental Therapeutics, Cancer Molecular Genetics and Cancer Cell Signaling programs.
Developing a New "Vaccine" for Metastatic Cancers
• Lymphocytes (LYM-fo-cites) are types of white blood cells. • B cells are kinds of lymphocytes. • T cells are kinds of lymphocytes. • Natural killer cells are kinds of lymphocytes. Photo and information courtesy of NCI 2 • Advance
Xiang-Yang Wang, PhD
Massey researcher Xiang-Yang Wang, PhD, Harrison Scholar and member of the Cancer Molecular Genetics research program, has recently published
Figure 1
Using New Immunotherapy to Treat Blood Cancer
Immune system T cells without azacitidine and lenalidomid
Azacitidine activates antigens
Antigens unlock T cells
With lenalidomid, T cells boosted and released to act as killer arsenal
Killer arsenal attacks cancer cells
results of a pre-clinical cutting-edge study in which an engineered immune modulator called Flagrp-170 was used to achieve localized vaccination on melanoma, prostate and colon tumors. Flagrp-170 consists of two distinct proteins. One of these proteins, known as Grp170, is currently being explored for use in the development of a "cancer vaccine," because it has been shown to help the immune system recognize cancer cells that normally have the ability to suppress the body's natural defense system. When combined with a fragment of another protein, flagellin, the immune system is activated in a unique
way that promotes apoptosis, or cell suicide, in cancer cells. Wang conducted a study that showed a positive response in animal models of melanoma, prostate and colon cancers. The study was recently published in Cancer Research, and Wang and his team continue to gain more understanding of the molecular mechanisms responsible for Flagrp-170's therapeutic effects. Additional studies are underway that hope to efficiently target and deliver the molecule to tumor sites for an even stronger response. "This immunotherapy has the potential to be used alone or in combination
with conventional cancer treatments to develop and establish immune protection against cancer and its metastases," says Wang.
Tapping Into T Cells to Combat Breast Cancer Masoud Manjili, DVM, PhD, member of the Cancer Cell Signaling program at Massey, is also at the forefront of groundbreaking research on cancer immunotherapy by targeting and manipulating specific parts of cancer cells. continued on page 4 Spring 2013 • 3
Immunotherapy continued
Amir Toor, MD; Masoud Manjili, DVM, PhD; and Catherine Roberts, PhD with Massey clinical trial participant Glenda Mincey. Manjili and his team focused on overcoming two major barriers of cancer immunotherapy: tumor-induced T cell suppression and T cell-induced tumor editing and relapse. The T cells are a family of immune system cells that keep people healthy by identifying and launching attacks against threats such as bacteria, viruses or cancer. Anti-tumor T cells can both stop or slow down tumor growth on the one hand, but also cause changes in the tumor cells that could lead to tumor relapse on the other hand. "The ultimate goal of immunotherapy is to overcome tumor-induced immune suppression and at the same time induce tumor rejection without facilitating tumor escape and relapse," says Manjili. Through lab studies led by Manjili, Massey researchers effectively reprogrammed cells of the innate and adaptive immune systems to overcome a key cancer defense mechanism and develop long-lasting memory to reject breast cancer cells, guarding against tumor relapse. In a study published in the Journal of Immunology, the researchers discovered a way to improve Adoptive Cellular Therapy (ACT), a treatment for breast cancer that taps into the immune system, by activating certain cells which enhance T cells capability to fight blood-forming cells. These findings could lead to clinical trials that test whether using immuno-
4 • Advance
therapy in a neoadjuvant (prior to surgery) or adjuvant (after surgery) setting in breast cancer patients with a high risk of relapse could prime the patient's immune system, much like a vaccine, to prevent the likelihood of relapse.
Unlocking New Treatments for Blood Cancers Translating Manjili's research into clinical application is Amir Toor, MD, hematologist-oncologist in the Bone Marrow Transplant Program and research member of the Developmental Therapeutics program at Massey. Toor's research concentrates on training the immune system to prevent cancer cells from evading detection and destruction. Focusing on T cells and the important role they play in warding off cancer cells, Toor and his team of investigators launched a two-pronged approach. The first step was directed at devel oping safe and non-toxic treatments to perform allogeneic (donor) stem cell transplantation. The second step involved understanding the donor immune system's response to cancer in donor stem cell transplantation to develop a way to train the patient's immune system to attack the cancer cells, ultimately allowing the patient to benefit from the immunotherapeutic
effect without the accompanying risk. The clinical trials developing these ideas have focused on utilizing either the donor's or the patient's own T cells to kill cancer cells. Toor says that the process works much like locks and keys. "The small antigens on the surface of foreign cells are keys and each T cell has a receptor or a lock," he says. "If the antigen on the threatening cell fits in the T cell receptor, then the lock is released and the T cell's deadly arsenal is unleashed on the threat. For the recipients, the keys are proteins unique to the patient and are absent in the donor, thus becoming targets for the donor T cells." Another Phase II clinical trial led by Toor is showing promise in providing lasting protection against the progression of multiple myeloma following an autologous (self ) stem cell transplant. Exemplifying the lock and key analogy, a combination of two drugs is trying to make cancer cells easier targets. The first drug, azacitidine, forces the cancer cells to express proteins – the keys – which the patient's T cells – the locks – recognize as foreign. The second drug, lenalidomid, boosts the production of the T cells to recognize and attack the foreign cancer cells (see Fig. 1, pg. 3). In short, Toor is harnessing the immune system to improve stem cell transplant outcomes while gaining mechanistic insights into the process. The approach, which has led to a number of publications and is gaining national attention, is now being used to treat a number of cancers, including leukemia and multiple myeloma. To date, this therapy has benefitted more than 50 cancer patients treated at Massey. Toor is also collaborating with Manjili and Gregory Buck, PhD, VCU Center for Genome Complexity, in an effort to catalogue the entire library of antigens that differ between stem cell donors and transplant recipients enrolled in a Phase II clinical trial. Through this project, the researchers hope to expand the selection of stem cell donors for those needing transplants.
Sparks of Discovery New Therapy Discovered for Several Forms of Blood Cancer
aboratory experiments conducted by scientists at VCU Massey Cancer Center suggest that a novel combination of the drugs ibrutinib and bortezomib could potentially be an effective new therapy for several forms of blood cancer. The study, published in the British Journal of Hematology, showed that the drug combination killed cancer cells through a form of cell suicide known as apoptosis, but was relatively non-toxic to normal, healthy cells. Ibrutinib is a new agent that inhibits the B-cell receptor signaling complex, which plays an important role in the survival of malignant B-cells. The interaction of the two drugs proved lethal even to lymphoma cells that had become resistant to bortezomib, currently used to treat mantle cell lymphoma and multiple myeloma, when used alone. "We are hopeful that this combination therapy may circumvent such resistance and eventually help fill an urgent need for more effective therapies for patients with these uncommon blood disorders," says the study's principle investigator Steven Grant, MD, Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational research, program co-leader of Developmental Therapeutics and Cancer Cell Signaling research member at Massey.
Steven Grant, MD
Viagra Drug Trio Improves Effectiveness of Cancer Treatment While Protecting the Heart
Rakesh Kukreja, MS, PhD
ith nearly half of all cancer survivors dying from other conditions than cancer, most notably cardiovascular disease, researchers at VCU Massey Cancer Center have found a drug combination to improve the effectiveness of cancer treatment while protecting the heart from harm caused by a popular form of chemotherapy. Recently presented at the American Heart Association's Scientific Sessions in Los Angeles, the study was co-authored by Rakesh Kukreja, MS, PhD, researcher in the Developmental Therapeutics program at VCU Massey Cancer Center and scientific director at VCU Pauley Heart Center.
The research team used breast cancer cells and cardiomyocytes, or heart cells, to study the effects of combining three drugs. The three drugs included cancer-fighting chemotherapy doxorubicin, erectile dysfunction medication Viagra and immunosuppressant antibiotic rapamycin. One of the drugs, doxorubicin, has been a powerful and effective drug for patients with various types of cancer for decades. Unfortunately, the drug can cause harmful and irreversible side effects to the heart. In earlier studies, Kukreja and his colleagues found that administering Viagra before doxorubicin prevented heart damage in mice while triggering cell death in prostate cancer cells. They also found that rapamycin protects the heart against tissue damage following acute heart attack. "Because Viagra and rapamycin are clinically approved drugs that both protect heart muscle, we thought that combining these with doxorubicin would be a promising strategy to eliminate the cardiac side effects of the drug while further improving its cancer-killing ability. Such a unique combination has never been used before," said Kukreja. Researchers discovered that the new 'drug trifecta' not only improved the anti-cancer effects of doxorubicin, but to also reduced damage to the heart caused by doxorubicin. Researchers say the next step in the study will be to demonstrate how the drug trio improves cancer treatment in animal models with human cancers. Also, more research is needed to understand how Viagra and rapamycin work together to improve doxorubicin treatment. SPARKS continued on page 6
Spring 2013 • 5
Sparks of Discovery
Scientists Discover How Deadly Skin Cancer Spreads
n important factor in understanding how a specific gene contributes to the spread of skin cancer and possibly a variety of other cancers has been discovered by scientists at VCU Massey Cancer Center. Published in the journal Cancer Research, the study demonstrated that mda-9/syntenin regulates the expression of several proteins responsible for promoting angiogenesis, the process that causes the formation of new blood vessels in tumors. The study's lead author was Paul B. Fisher, MPh, PhD, Thelma Newmeyer Corman Endowed Chair in Cancer Research and program co-leader of Cancer Molecular Genetics at Massey and chairman of VCU's Department of Human and Molecular Genetics. "Our research brings us one step closer to understanding precisely how metastatic melanoma, a highly aggressive and therapy-resistant cancer, spreads throughout the body," says Fisher. "Additionally, analysis of the human genome has indicated that mda-9/syntenin is elevated in the majority of cancers, which means novel drugs that target this gene could potentially be applicable to a broad spectrum of other deadly cancers." The researchers are now focusing on developing novel small molecules that specifically target mda-9/syntenin and IGFBP-2, which could be used as drugs to treat melanoma and potentially many other cancers.
Paul B. Fisher, MPh, PhD
Multiple Sclerosis Drug May One Day Treat Colorectal Cancer
Sarah Spiegel, PhD
6 • Advance
cientists from VCU Massey Cancer Center have found that fingolimod, a drug currently approved for the treatment of multiple sclerosis, could potentially eliminate or reduce the progression of colitis-associated cancer (CAC). The study, published online in the journal Cancer Cell, was led by Sarah Spiegel, PhD, Mann T. and Sara D. Lowry Chair in Oncology, co-leader of the Cancer Cell Signaling program at Massey and chair of the Biochemistry and Molecular Biology Department at the VCU School of Medicine. The team discovered that increased production of an enzyme, sphingosine kinase 1, causes cells lining the intestine to produce more of a signaling molecule known as sphingosine-1-phosphate, activating a variety of biological mechanisms that lead to chronic intestinal inflammation and the development and progression of CAC. The researchers then used animal models to demonstrate that the drug fingolimod decreased expression of the enzyme and the signaling molecules receptor, which also interfered with the development and progression of CAC, even after tumors were established. "Perhaps the most significant aspect of this study is the therapeutic potential of fingolimod in the treatment of colitis-associated cancer," says Spiegel. "Since this drug is already approved for clinical use, we're hoping to initiate a clinical trial to study its efficacy in patients with CAC, in combination with approved therapies." The next step in the team's research is to examine blood samples from patients with irritable bowel syndrome and colitis-associated cancer to measure levels of the signaling molecule, sphingosine-1-phosphate.
Researchers Apply Insights Gained From Nature to Understand Immune System
ecently published in the journal Biology of Blood and Marrow Transplantation, a study of 10 unrelated stem cell transplant donors and recipients Amir Toor, MD, hematologistoncologist in the Bone Marrow Transplant Program and research member of the Developmental Therapeutics program at Massey, found a fractal pattern in their T cell repertoire. The fractals — or selfsimilar, repeating patterns in nature — can help scientists better understand how the immune system is organized and may one day be used to improve stem cell transplant outcomes in leukemia patients by predicting the probability of transplant complications. T cells are a family of immune system cells that keep individuals healthy by identifying and launching attacks against threats such as bacteria, viruses or cancer. T cells have receptors that recognize small antigens on the surface of foreign cells. They work much like a lock and key, where the antigen on the threatening cell fits in the T cell receptor
like a key and then the T cell's deadly arsenal is unleashed on the threat. The research team led by Toor, looked at the T cell repertoire in stem cell transplant donors and recipients following stem cell transplantation. In healthy donors, Toor observed the self-similar repeating pattern among their T cell receptor families within and across different individuals. In patients who received a stem cell transplant, Toor found that this pattern was disrupted and the patients displayed a lower level of complexity in their T cell receptor repertoire three months after transplant, followed by a modest improvement when a full year elapsed after transplantation. "Our findings lend an insight into nature, such that, even in complex biological systems bereft of physical form, mathematically determined organization is observed," says Toor. "We're hopeful that this information will give us clues that will help us better understand the recovery of the immune function following stem cell transplantation and possibly
Amir Toor, MD predict complications such as graft-versus-host disease in transplant recipients." The team plans to continue to study patients' T cell receptors to learn more about how the immune system recovers following stem cell transplantation, in hopes of discovering valuable information about the effectiveness of future stem cell transplant and immunotherapy clinical trials.
For additional details and more research news from VCU Massey Cancer Center, visit http://blog.vcu.edu/massey_news
Gifts with a Lasting Impact
Mother's Day and Father's Day Tribute Cards VCU Massey Cancer Center invites you to celebrate your mother, father, grandparent or other loved one with a donation supporting life-saving cancer research. For each $25 donation, we will send a customized card notifying the honoree of your gift. If you wish to honor multiple people, you may make a $100 donation and we will send five cards to the loved ones of your choice. To view full selection and order, please visit www.support.vcu.edu/MasseyTribute.
Happy Mother's Day A gift has been made to VCU Massey Cancer Center In honor of Mom You are our inspiration! Love, Susan and John This gift will allow VCU Massey Cancer Center to continue its mission: To improve the quality of human life through the prevention, control and cure of cancer.
Spring 2013 • 7
Centerpieces Life and Love After Cancer
ow are you loving life after cancer? That is the question VCU Massey Cancer Center is asking through a new Life and Love After Cancer marketing campaign. Launched in February, the campaign aims to provide hope in the face of cancer by asking survivors to share how they recaptured the things they love in life after cancer. The campaign's centerpiece is a unique website (http:// www.lifeandloveaftercancer.com/) where cancer survivors can not only share their personal story through text and images, but also view other stories and interact through social media. The website features a wide variety of stories that vary in cancer types, age and passion, all while sharing the common bond of reviving a love after cancer. The survivors who have shared so far have left inspiring words and some of the stories are highlighted below.
• Mary, a 17-year-old double survivor of Ewing Sarcoma from Farmville, Virginia discovered love of equestrian competitions and is now a top 15 world champion in Hunter Under Saddle quarter horse competitions. • Bob, an oral cancer survivor in his late 50s living in New Hampshire, rediscovered love of the outdoors and is currently hiking and camping in the backcountry of Africa and America. • Carolyn, a breast cancer survivor in her 50s from Richmond, published a book of her journal that chronicled her cancer journey and now enjoys speaking to women's groups. • Daisy, a lymphoma survivor in her 60s living in Northern Virginia, is now back to jogging, doing yoga and enjoying her grandchildren.
Three New Clinical Trials Available Prostate Cancer:
Mitchell Anscher, MD, is conducting a Phase II clinical trial studying shortened radiation therapy for prostate cancer. Melanoma:
Members of the Medical College of Virginia Hospitals (MCVH) Auxiliary (left to right) Ann Carter, Maxine Brewer, Valli Duval, Mary Gill, Lois Trani, Linda Krauth, Dr. Dean Goplerud, Judy Hanshaw, Karen Shudtz, Fara Caldwell and JoAnn Burton
Palliative Care on Wheels
ith funds provided by the Medical College of Virginia Hospitals (MCVH) Auxiliary, volunteers from the Thomas Palliative Care Unit developed a cart full of materials for activities that offer comfort to patients and their families, as well as tools for nurses to enhance care. The activities fostered by the cart provide patients with an outlet to talk about their illness and gives them ways to create memories with their families. Hospital volunteers stock the cart with blankets, handprint-making tools, books, crayons, paints and other items.
8 • Advance
Andrew Poklepovic, MD, is the principal investigator for a Phase II and Phase III melanoma trial studying the treatment of patients with high-risk melanoma that has been removed by surgery. Ovarian Cancer:
Weldon Chafe, MD, is conducting a Phase III clinical trial focusing on lifestyle intervention to reduce risk of ovarian cancer recurrence. Learn more at www.masseytrials.com.
Welcome New Massey Members!
assey Cancer Center research membership is open to research investigators, clinicians, cancer survivors, patient advocates and community leaders engaged in and/ or supportive of cancer-related research. Membership eligibility and privileges are defined by a candidate's level of current cancer-related research activity. Please join us in welcoming the following new scientists as Massey Members:
Stony Point Facelift
• Larisa Litovchick, MD, PhD,* Cancer Molecular Genetics program
• Michael F. Miles, MD, PhD, Cancer Molecular Genetics program
Recently Awarded Massey Pilot Projects
Faculty Honors
assey's hematology/oncology clinic and Lois Trani Patient Resource Library at Stony Point have a fresh new look. Recent cosmetic renovations brightened up the satellite location of Massey with new flooring, paint, furniture and fabric in the waiting area and treatment space. The library was also improved and now has more space to accommodate small gatherings and meetings, as well as easier visibility and access for patients. "The comfort of our patients is always top-of-mind," says Mary Ann Hager, associate director for oncology services. "These improvements bring a serene environment to compliment the high caliber of care and resources available to those we serve."
assey offers funding for pilot projects to encourage new collaborative cancer research projects and to provide initial funding for new, collaborative projects with significant involvement of at least two independent investigators. Massey research members and associate members are eligible to apply for up to $30,000 for a one-year project. Below is a list of Massey's most recent grant recipients:
Richard F. Brown, PhD, Cancer Prevention and Control Program
"Developing an Online Clinical Trial Specific Question Prompt List" This project aims to test innovative methods to bolster patients and physician use of Question Prompt Lists (QPLs), a method that has been shown to aid patient-physician consultation communication. Yi Ning, MPH, MD, ScD, Cancer Prevention and Control Program
"Genetic Variants, Diabetes and Adverse Late Effects of Radiation Therapy" This project will conduct a study investigating genetic variants, medical treatment, and socio-demographic factors as predictors of the adverse late effects of radiation therapy, its severity, and its pervasiveness. Lynne Elmore, PhD, Cancer Molecular Genetics Program
"Senescence and Cognitive Function in Women with Breast Cancer" In this pilot study, the investigators begin to examine whether patient-derived cells age in response to chemotherapy.
• Iain Morgan, PhD, Cancer Molecular Genetics program *Litovchick is also a new VCU physician scientist with the Division of Hematology, Oncology and Palliative Care and was recently named a Harrison Scholar.
• Paul B. Fisher, MPh, PhD, presented as part of the Distinguished Speaker Series at the Cancer Grant Rounds at the University of Texas Southwestern Medical Center at Dallas. • Christopher R. Johnson, MD, has been named an Associate Editor of the journal Radiology. • Amir Toor, MD, was a featured speaker at TEDxRVA, an event "uniting extraordinary people through inspired and profound discussions." • Jeffrey F. Williamson, PhD, has been named Editor in chief of the journal Medical Physics. Spring 2013 • 9
Cancer Prevention and Control Simpler Colonoscopies Are Safer
he number of colonoscopy procedures is expected to surpass 14 million per year, according to the United States Centers for Disease Control and Prevention (CDC). Colonoscopy is the most common form of colorectal screening and uses a flexible fiber-optic tube to check for cancer or polyps (growths that can be removed before they turn into cancer) in the colon or rectum. Although colonoscopies are relatively safe, there are risks. A new study by VCU Massey Cancer Center researchers discovered that as the complexity of colonoscopies increases, there is a higher risk of adverse events. Published in the journal Gastrointestinal Endoscopy, the retrospective study was led by Aksar Chukmaitov, MD, PhD, assistant professor in the Department of Healthcare Policy and Research at Virginia Commonwealth University School of Medicine, who analyzed hospitalizations that were linked to colonoscopy procedures that caused serious adverse events within 30 days. The research found that the risks of adverse events were higher for procedures performed by low-volume endoscopists, which were classified as
less than 300 cases per year. Regarding facility type, the researchers found that outpatient colonoscopies provided at ambulatory surgery centers were associated with higher risks of adverse events than hospital outpatient departments. "This issue could be addressed by monitoring surgeon volume and by urging primary care physicians to refer patients to experienced endoscopists who perform a high volume of colonoscopies," said Chukmaitov. The researchers also found that "simple" colonoscopies, ones without polypectomy (which is surgery to remove polyps) are associated with the lowest risk of adverse events and that the use of cold biopsy forceps over hot biopsy forceps, when applicable, had better outcomes. As for colonoscopies with polypectomy, ablation which burns the polyps with laser-like devices, was associated with the fewest adverse events. "Given the large number of colonos copies performed each year in the United States, a reduction in the rates of adverse events will substantially reduce patient morbidity and mortality as well as health care costs," said Chukmaitov. The American Cancer Society recommends that people who have no
Aksar Chukmaitov, MD, PhD identified risk factors should begin regular screening at age 50. Those who have a family history or other risk factors for colorectal polyps or cancer should talk with their doctor about starting screening at a younger age and/ or getting screened more frequently.
Stay Safe This Summer Tips to Reduce Your Risk for Skin Cancer • Seek shade, especially during midday hours. • Wear clothing to protect exposed skin. • Wear a hat with a wide brim to shade the face, head, ears, and neck. • Wear sunglasses that wrap around and block as close to 100% of both UVA and UVB rays as possible. • Use sunscreen with sun protective factor (SPF) 15 or higher, and both UVA and UVB protection. • Apply 1 ounce (2 tablespoons) of sunscreen to your entire body 30 minutes before going outside. • Avoid indoor tanning. • Examine your skin head-to-toe every month.
Tips courtesy of cdc.gov and skincancer.org
10 • Advance
Understanding Minority Participation in Clinical Trials
assey researcher Lynne Penberthy, MD, PhD, led a team of Massey researchers to study the reasons why Caucasian and African-American patients who are offered a clinical trial are ineligible or refuse to participate. Penberthy's team discovered that Caucasian patients are more likely to be ineligible to participate due to their type of cancer or characteristics specific to the study. African-American patients were more likely to be ineligible because they were unable to provide informed consent or had challenges with compliance, such as the inability to attend appointments due to lack of transportation. As for reasons for refusal, Caucasian patients were more likely to refuse due to the extra burden related to traveling to the additional clinic visits that clinical trials often require; preference for
their own physician versus the physician leading the trial; or concerns about randomization or toxicity. African Americans were more likely to refuse due to lack of interest in a clinical trial, family pressures or feeling overwhelmed by their diagnosis. "It is important for clinical trials to have participants from all different ages, races, sexes and ethnicities, so that the results can have a much wider applicability and, therefore, medical advancements can help more patients," said Penberthy. "But unfortunately, there continues to be a huge gap between Caucasian and minority participants despite the National Institutes of Health's 20 years of focus on increasing minority participation." According to the Center for Information & Study on Clinical Research Participation, of the 75,215
patients who enrolled in National Cancer Institute-sponsored clinical trials from 1996 to 2002, 85.6 percent were Caucasian, 9.2 percent were African American, 3.1 percent were Hispanic, 1.9 percent were Asian/Pacific Islanders and 0.3 percent were American Indians/ Alaskan Natives. The goal of this research is to inform cancer centers of patient barriers so that they can close the accrual gap in minorities by addressing the barriers specific to their minority patients. To help improve the clinical trial process, Penberthy suggests that cancer centers select clinical trials that are most appropriate for their population and change the eligibility criteria that restrict the participation of minority patients. The next step is to continue analyzing and gathering data to support further studies that address minority accrual barriers.
Junius Hayes was the first patient in the United States to participate in a clinical trial testing an inflatable biodegradable balloon and its effectiveness of providing less damage to the healthy areas surrounding the prostate during radiation treatment for prostate cancer. Hayes' extensive knowledge in the scientific field led to his participation in the clinical trial but as Lynne Penberthy discovered, the decision to participate in a clinical trial can be overwhelming for a majority of people.
Spring 2013 • 11
Investments in Progress Research for Life Campaign Update
CU Massey Cancer Center's Research for Life Campaign continues to gain momentum following its public launch in November. With more than $78 million raised toward the campaign's $100 million goal, the opportunity for partnering in the expansion of Massey's people, places and programs is engaging more donors than ever in all types of giving, from annual gifts, to event participation to significant major gifts.
Recent notable gifts include: • Mr. and Mrs. C.T. Hill (above) committed $250,000 to the campaign. Hill, a longtime member of the Massey Advisory Board is currently serving as co-chair of the Research for Life Campaign. The gift combines a $50,000 commitment from the C.T. Hill and Moira Hollander Hill Charitable Fund with a $200,000 bequest from C.T. Hill. In recognition of this gift, a conference room in Massey's Research Pavilion in the McGlothlin Medical Education Building will bear the Hill's name. • Mr. and Mrs. Frank E. Laughon, Jr. (right) made a $100,000 gift on behalf of their daughter, Page, her husband, Jeffrey, and their children Ashe and Kaki. The gift was made from the Stuart B. and Frank E. Laughon, Jr. Charitable Fund of The Community Foundation Serving Richmond & Central Virginia. The donation from the Laughon family, 12 • Advance
Goal: $100 million Funds Raised: $78 million
which was made in honor of Gita Massey, MD, and India Sisler, MD, pediatric oncologists, supports a joint effort between Massey and VCU's Department of Pediatric Oncology to establish an endowed chair in pediatric cancer research. Once fully funded, the chair will assist in the recruitment of a nationally-recognized physician-scientist with a solid background in basic, clinical and translational research. Thanks to generous supporters, the fund has currently raised over $400,000 towards a $1 million goal.
Glasgow Incentive
Massey's supporters continue to take advantage of the "Glasgow Incentive," through which gifts of $500,000 or more to an endowment will allow for funds to be drawn from the Glasgow Trusts in a matching amount— essentially doubling a donor's gift and its intended impact. Recent gifts that have utilized the Glasgow Incentive include: • Through their foundation, Universal Corporation recently committed an additional $500,000 to VCU Massey Cancer Center. This gift will elevate the existing Universal Corporation Distinguished Professorship, held by Paul Dent, PhD, since its creation in 2003, to the Universal Corporation Endowed Chair in Cancer Cell Signaling and will continue to support Massey's notable work in cell signaling. "Although our foundation is not large, we decided that we want to have a significant impact on Massey and, in particular, on Dr. Dent's groundbreaking research," said George C. Freeman III, chairman, president, continued on page 13
(Left to right) Ashe Allende; Page Allende; Gita Massey, MD; India Sisler, MD; Kaki Allende and Jeffrey Allende.
Research for Life Campaign Update continued and chief executive officer of Universal Corporation. "Universal believes in the work being performed at Massey, and this gift is a reflection of our commitment to furthering the fight to defeat cancer." • John R. "Jack" Congdon, Sr. committed $500,000 and engaged the Glasgow Incentive to create the Natalie N. and John R. Congdon, Sr. Endowed Chair in Cancer Research. The gift was made through the Natalie and Jack Congdon Charitable Fund of The Community Foundation Serving Richmond & Central Virginia. It is the second significant gift to Massey that Congdon has made. A previous $500,000 gift in 2010 supported Massey's Statewide Clinical Research Affiliation Network.
(Left to right) Advisory Board members Judy Turbeville, Dianne Harris Wright, Ted Chandler (Chair), Cessie Howell, and Ann Austin
Advocacy Pays Off
wo years ago, Governor Bob McDonnell allocated $7.5 million per year in the biennial budget to support cancer research at Massey. The amended budget for fiscal year 2014 that was passed by the General Assembly included an additional $1 million for cancer research at both Massey and the University of Virginia. Advocacy from volunteers, donors, patients and staff is essential in reinforcing to our legislators that funding cancer research is crucial to creating a cancer-free Virginia. January's annual morning of advocacy, dubbed "Massey Day on the Hill," had more than 60 staff and volunteer advocates canvassing the General Assembly building with a message of Massey's mission and information about how Massey's research, education and patient care reaches all corners of Virginia.
Thomas Palliative Care Program Receives New Support
assey Cancer Center's Thomas Palliative Care Program is a national leader in providing compassionate, holistic care to alleviate suffering and maximize quality of life of those with cancer and other chronic diseases. The program's clinicians and physician-scientists are also committed to expanding research and education related to this growing segment of cancer care. Recently, several significant gifts have been directed to the program in support of their mission: • A generous gift from NewMarket Corporation created the Susan White Holsworth Palliative Care Scholar Endowed Fund to permanently support a skilled clinician who provides tailored and caring treatment options
to palliative care patients. Patrick Coyne, APRN, clinical director of the Thomas Palliative Care Program, was awarded the scholarship. NewMarket Corporation's gift to the palliative care program as well as a second gift establishing the Susan White Holsworth Patient Resource Library Acquisition Fund, was made in memory of Susan White Holsworth, a valued employee and Massey supporter, in recognition of her career as a librarian and in gratitude for the care she received at Massey during her illness. • The Jessie Ball duPont Fund invested $105,732 to support the launch of a one-year pilot project that will provide specialized education in
palliative care to advanced practice registered nurses (APRN). Targeted to APRNs who are practicing in rural or underserved areas of Virginia, the gift is intended to promote a better quality of life for Virginians with lifelimiting illnesses who may have more difficulty accessing quality care, and to create a model that can be applied on a national scale. • American Hospice Foundation committed $49,157, underscoring the longstanding partnership between Hospice of Central Virginia and Massey's Thomas Palliative Care Program. The gift will support the program's efforts in educating providers and the community about palliative medicine.
Spring 2013 • 13
Around the Commonwealth Project LIFE! Puts Faith in Churches to Influence Healthy Behavior
The Community Memorial Healthcenter (CMH) oncology team, led by Tzann Fang, MD
Massey Opens Clinical Trials in South Hill
hree Massey clinical trials are now open and enrolling patients at Community Memorial Healthcenter (CMH) in South Hill, Virginia, where Massey began providing medical oncology care in the summer of 2012. The partnership between Massey and CMH allows therapeutic trials to be offered through Massey to patients in the Southern Virginia region. Trials will focus on breast, colon and lung cancer after a needs assessment conducted by Massey deemed those cancer types the most prevalent in the region. Led by Massey physician Tzann Fang, MD, and CMH research nurse, Donna Robertson, RN, OCN, the research team enrolled their first patient in a trial at the end of March. The trial compares different treatment options for breast cancer, and is the first trial led by a Massey physician at a partner institution. "This offers patients the convenience of staying in their home town instead of traveling to Richmond for access to a clinical trial," says Marjorie Halverson, RN, OCN, clinical protocol activation manager at Massey, who has worked closely with the team in South Hill. The Massey clinical, regulatory, administration and affiliate research teams provided several comprehensive training sessions for the CMH staff leading up to the opening of the three clinical trials. These Massey research teams continued this collaboration over many months in order to implement all of the necessary steps to open these clinical trials at the South Hill location. Partnering with Massey's collaborative effort at CMH are Mary Hardin, RN, MSN, OCN, CMH Cancer & Specialty Care director; Donna Robertson, RN, OCN, lead research nurse; Julie Hamby, RN, BSN, OCN, and Teresa Collins, RN, research nurses. "Working with Massey to bring our patients access to these cutting-edge treatments is extremely gratifying," says Robertson. "We're committed to excellence in care and partnering with Massey underscores that commitment." "Clinical trials provide state-of-the-art care to patients and also allow the development of new therapies," says Halverson. "The opening of these clinical trials in South Hill marks another way in which Massey is spreading our research to different areas of the Commonwealth and engaging more patients in trials while providing the high level of care and expertise for which Massey is known."
14 • Advance
n early 2013, the American Cancer Society released a report revealing that cancer death rates are significantly higher among African Americans than Caucasians. Decreasing this disparity was one of the objectives behind Project LIFE! (Lord, Intimate relationships, Fitness and Early detection), which utilizes the power and influence of the African-American church to address this major health concern. "Our goal is to evaluate the impact on the behaviors of congregants when their church adopts a 'health and wholeness' pledge to practice and promote healthy behaviors," said project lead and VCU Massey Cancer Prevention and Control researcher Maghboeba Mosavel, MA, PhD. "The expected outcome is that there will be an increased knowledge of cancer screening resources; increase in screening; and more integration of healthy practices within the church." Project LIFE! is currently active in three churches in Danville and Pittsylvania, Virginia. Eleven congregants were trained to serve as LIFE! coaches to spread health promotion messages and host tailored activities aimed at increasing healthy behaviors and promoting early detection for cancer.
Maghboeba Mosavel, MA, PhD
Interactive Audiovisual Tool Developed to Educate Communities About Cancer Screenings
he Community Engagement Educational Program (CEEP), led by VCU Massey Cancer Prevention and Control researcher Arpita Aggarwal, MS, MD, recognized the significant disparities in patient knowledge of healthy behaviors, screening guidelines and resources available in the Piedmont and Mount Rogers health districts of Virginia and identified a need for community-based resources for preventive health education. CEEP developed an educational computer program, in partnership with the two districts, to test an interactive audiovisual tool, which reflects the community's language and culture, in providing information about recommended preventative cancer screening. The program is used by community facilitators and includes tutorials on cancer risk behaviors and recommended screening guidelines for cervical, breast, colorectal, prostate and skin cancers. "In addition to increasing health awareness in our partnering communities," said Aggarwal, "our long-term goal is to build community sustainability by developing local leaders and training community facilitators." The interactive tool is currently being tested in more than 400 participants in 20 towns of the two health districts.
Arpita Aggarwal, MS, MD
New Clinical Research Affiliates in Winchester and Fredericksburg
henandoah Oncology, PC, in Winchester, VA, and Mary Washington Healthcare in Fredericksburg, VA are the two newest clinical research affiliates of VCU Massey Cancer Center. Shenandoah Oncology has been caring for patients in the surrounding areas of Virginia, West Virginia, and Maryland since 1979 and opened their first Massey-affiliated clinical trial in March of 2013. The practice consists of several board-certified physicians specializing in oncology and hematology, as well as oncology-certified nurse practitioners. On-site services include a patient navigator, nutritional counseling, survivorship program, genetic counseling, support services program, radiation oncology, and surgical oncology.
"Our affiliation with Massey's research program provides access to Phase II and III clinical trials for both solid tumor and hematology diagnoses," says Claudia Phillips, RN, BSN, OCN, CCR, clinical research nurse at Shenandoah Oncology. "This ensures the most up-to-date care in the community setting and ensures all of our physicians are registered as investigators with the National Cancer Institute." The Mary Washington Hospital (MWH) Research Department was established in 2004 with a primary focus on cardiology studies and in 2007 broadened their scope to include oncology studies. In March of 2013, Massey's
affiliation with MWH was formed and will focus on providing clinical trials for lung cancer as well as cardiology research trials. Staffed by several certified clinical research professionals, the research program is under development and trials are expected to be active by the summer.
existing clinical research affiliate locations
NEW! Winchester
NEW! Fredericksburg
H Spring 2013 • 15
Special Events
Teaming Up With the YMCA to Support the HDL, Inc. Massey Challenge
assey Challenge committee members ran and walked with the more than 20 YMCA training teams as a way to encourage participation and say thank you for accepting the HDL, Inc. Massey Challenge. The YMCA Training Teams accepted the Challenge in creative ways by holding spare change drives, bake sales, barrel rides, and costume contests.
Richmond Christmas Gala
he Massey Alliance's 2nd Annual Richmond Christmas Gala presented by Northwestern Mutual was held on December 8, 2012. Friends and advocates came together for holiday festivity and raised more than $34,000 for cancer research at Massey.
Worth Bugg (right), Massey Challenge committee member, speaks to the Manchester YMCA 10k Training Team.
A spare change drive at a local YMCA branch to fundraise for the Massey Challenge. (Left to right) George Emerson, Advisory Board member; Governor Bob McDonnell, and Becky Massey, Research for Life Campaign co-chair.
Capitol Square Basketball Classic
he 5th Annual Capitol Square Basketball Classic was held on February 28 at the VCU Siegel Center. Pitting lobbyists versus the Governor and his staff, and delegates versus senators, the friendly evening of competition raised $15,000 for Massey.
16 • Advance
Black & Blue Classic Supports Massey
(Left to right) Doug Arthur, MD; Lee Woodruff, Shelly Arthur, event chair; and Gordon D. Ginder, MD, director, VCU Massey Cancer Center.
Women & Wellness
he 18th Annual Women & Wellness Forum Series was held on February 5 at the Jefferson Hotel and featured author Lee Woodruff, who left nearly 700 breakfast and lunch attendees inspired, empowered and ready for life's journey. This year's event netted more than $218,000 for women's cancer research at Massey and was presented in memory of Susan H. Fitz-Hugh.
hen crosstown rivals VCU and University of Richmond squared off against each other this season in men's basketball, a first-time partnership between the two schools was formed to channel the hometown rivalry to benefit and raise awareness for Massey. At each game, fans were provided with a customizable cheer sign to honor those who have battled cancer and show their support for cancer research at Massey. Games also included touching tributes and an emphasis on cancer awareness.
Massey Challenge Chair Kaity Kasper fuels up on Green Monster at the Ellwood Thompson Juice Bar before practicing yoga in the community room.
Live Local, Give Local.
VCU Women's Basketball Pink Out
n February 17, VCU Athletics teamed with VCU Massey Cancer Center to help raise breast cancer awareness during a VCU women's basketball game at the Siegel Center. A special halftime presentation featured former and current Massey patients, where they were recognized at half court and honored by the fans in attendance.
n an effort to broaden the reach and expand community involvement during this year's HDL, Inc. Massey Challenge, local businesses hosted events and donated proceeds to Massey. Examples included Ellwood Thompson's Natural Food Market and Yoga Source hosting more than 25 yogis for a benefit yoga night and Cafe Caturra hosting an evening where a portion of sales were donated to the Challenge.
Spring 2013 • 17
Virginia Commonwealth University Massey Cancer Center P.O. Box 980214 Richmond, Virginia 23298-0214
Non-profit Org. U.S. Postage Paid Richmond, VA Permit No. 869
Events Calendar May 1
Federal Reserve Golf Tournament Chesdin Golf Club
May 2
Lunch and Learn: Yoga, a Useful Tool! 12:00–1:00 VCU Massey Cancer Center at Stony Point To register, please call (804) 628-1550
June 8
11th Annual Moonlight Magic presented by Hunton & Williams 6:30–10:30 pm James River Cellars Tickets now available at www.massey.vcu.edu/moonlight
May 16
Secret Garden Party 5:30–8:30 pm Becky's Healing Garden and other downtown gardens www.rvasecretgardenparty.com
May 16
Piankatank Golf Tournament Piankatank Golf Club
May 30, June 6, 13, 20
Living Well with Cancer: Yoga for Survivors 4:00–5:00 pm YMCA Richmond To register, please call (804) 628-1550
For more details on these and other events, visit www.massey.vcu.edu/support or call (804) 827-9486. Follow Massey on Facebook at www.facebook.com/VCUMasseyCancerCenter.
Published on May 2, 2013
VCU Massey Cancer Center's publication for supporters, volunteers and friends.


text:
is the budget gonna destroy my life???
is the budget gonna destroy my life???
Brad McNamara @bbuzzmc
Will say this once and then nothing else. Defamation laws quite clear in Aus.be careful.
the evil flood levy is finally over!
seems like it makes financial sense to go back to high school. how does one do this
serious post:
pretty annoying that the buisness cut isn't being introduced. I guess they wasn't any point 'cause the greens had been pretty clear that they wouldn't let it through, but still.
R.I.P Craigos, you were a champion bloke. One of the best
R.I.P Fardin 'Bob' Qayyumi
Member of the Church of the Holy Glenn McGrath
"How about you do something contstructive in this forum for once and not fill the forum with ****. You offer nothing." - theegyptian.
"There's more chance of SoC making a good post than Smith averaging 99.95." - Furball
"**** you're such a **** poster." - Furball
Should be one of the interesting parts of them getting into power.
That and watching Tony Abbott get shot in Indonesia when he visits the first week he's in power to tell them they have to stop sending boat people to Australia.
Last edited by Son Of Coco; 08-05-2012 at 07:08 AM.
However, literally the only reason why I support the Libs in Oz is that they generally wont **** the country whilst forwarding their own personal agendas
By way of contrast, the ALP are a dangerous joke as they will promote their own agenda AND **** the country.
No better example of this can be found than in the case of Craig Thomson
Rather than standing the guy down, the "honourable" PM has prevailed upon the alleged fraudster to sit on the cross benches so that he can continue to vote ALP, maintain her tenuous grip on power and he is only to happy to oblige as his super payout grows every day
Whilst I personally believe that Abbott is in no way a great candidate for PM, the current situation is very sad and an extremely poor reflection on a great country
No Budget bounce for Labor, I am predicting
- Winner of the 2011 and 2012 CricketWeb AFL tipping competition
- Winner of the 2011, 2012 and 2013 CricketWeb NRL tipping competition
The federal opposition has abandoned its principle of opposing all the measures the mining tax will fund and support $2.9 billion in welfare increases to be funded by the levy.
Pretty meh budget really. Nothing really bad, nothing really good.
uhAsked how cash payments of baby bonus and school bonus are any different, Opposition Leader Tony Abbott says 'well look, they just are.'
do you think people will be allowed to make violins?
who's going to make the violins?
forever 63*
that is not a real quote
you're messing with us and I do not appreciate it one bit
latika says it is, so it is
There are currently 1 users browsing this thread. (0 members and 1 guests)

subset: commoncrawl


text:
- Subscribe
AdvertisementAdvertisementLet's Stay In Touch
- Subscribe
Lucky for you, your favorites—along with ice-skating—are considered the top winter workouts. The reason: Each one requires continuous effort without rest, so your heart rate stays up, increasing the cardiovascular benefits. (Prefer to blast fat indoors? Check out these 4 metabolism-boosting moves.)
"Plus, cold weather forces your body to exert more energy to stay warm, which translates into extra calories burned," says Prevention advisor Wayne L. Westcott, PhD, fitness research director at the South Shore YMCA in Quincy, MA.
You may unsubscribe at any time.
Even the weight of added layers of clothes, such as knit hats and down jackets, helps intensify the burn. (It's true. Watch our fitness editor show you how to layer for cold-weather workouts.) Check out our handy chart below to see how some of the most popular winter activities compare.
Sport Calories* Target Areas To boost the burn Snow-shoeing 544 Abs, thighs, calves Use poles to give your upper body a workout, too. Cross-country 510 Shoulders, arms, thighs Raise your arms to shoulder height to improve the cardio benefit. Ice-Skating 425 Thighs, calves Go backward to challenge your leg muscles even more. Downhill Skiing 374 Abs, thighs, butt Follow an exaggerated zigzag pattern while descending to work your core harder.
*burned per hour based on a 150-pound womanCopyright © 2017 Rodale Inc.
Using your Email Address{* #signInForm *} {* signInEmailAddress *} {* currentPassword *}
Or an account with{* loginWidget *}
Sign In
Welcome back, {* welcomeName *}!{* loginWidget *}
Sign In
Welcome back!
Deactivated Account
Your account has been deactivated.
Almost Done!
Please confirm the information below before signing in.{* #socialRegistrationForm *} {* emailAddress *} {* displayName *} By clicking "Sign in", you confirm that you accept our terms of service and have read and understand privacy policy.
Almost Done!
Please confirm the information below before signing in. Already have an account? Sign In.{* #registrationForm *} {* emailAddress *} {* displayName *} {* newPassword *} {* newPasswordConfirm *}
Thank you for registering!
We have sent a confirmation email to {* emailAddressData *}. Please check your email and click on the link to activate your account.
Create a new password
We'll send you a link to create a new password.{* #forgotPasswordForm *} {* signInEmailAddress *}
Create a new password
We've sent an email with instructions to create a new password. Your existing password has not been changed.
{| current_emailAddress |}
{| foundExistingAccountText |} {| current_emailAddress |}.
{| existing_displayName |} - {| existing_provider |} : {| existing_siteName |} {| existing_createdDate |}
{| existing_provider_emailAddress |}
Sign in to complete account merge
Resend Email Verification
Sorry we could not verify that email address. Enter your email below and we'll send you another email.{* #resendVerificationForm *} {* signInEmailAddress *}
Your Verification Email Has Been Sent
Check your email for a link to reset your password.
You did it!
Thank you for verifiying your email address.
Change password
Your password has been changed
Password has been successfully updated.
Create a new password
We didn't recognize that password reset code. Enter your email address to get a new one.{* #resetPasswordForm *} {* signInEmailAddress *}
Create a new password
We've sent an email with instructions to create a new password. Your existing password has not been changed.
Linked Accounts
Link your accounts
Allows you to sign in to your account using that provider in the future.
Deactivate Account
Change password
Deactivate your Account
Are you sure you want to deactivate your account? You will no longer have access to your profile.{* deactivateAccountForm *}
Almost Done!
Please provide the information below before signing in.{* #requiredFieldsForm *} {* displayName *}


text:
EDMONTON, Alberta — Despite surrendering third-period goals to Kyle Brodziak and Eric Cole, the latter on the power play, Ducks goaltender Jonas Hiller matched a regular-season franchise record with 51 saves in Friday night's 3-2, shootout victory over the Edmonton Oilers at Rexall Place.
"Obviously, he was the best player on the ice," Ducks coach Randy Carlyle said.
Cole's equalizer, at 13:57, resulted from the ninth of 10 Oilers power-play opportunities, five of which came in the third period. Buoyed by 15 shots with the man advantage, Edmonton out-shot the Ducks 21-4 in the third period.
"Sometimes it's good to have a lot of shots," Hiller said. "It was a tiring game, but I felt good. For sure, I'm happy with the win."
The Ducks (18-12-3) broke on top on a short-handed goal by Rob Niedermayer, assisted by Scott Niedermayer, at 19:39 of the first period. The Ducks converted on the power play for just the second time in 26 opportunities over parts of seven games when Corey Perry re-directed a Bobby Ryan shot past Oilers goalie Dwayne Roloson at 10:09 of the second period.
On the first attempt of the shootout, Perry skated nearly to the right-wing boards before cutting to the net and, utilizing remarkable patience, beating Roloson from close range.
"It's something that's worked in the past," Perry said. "If you can get wide, you can get a little better angle on the goalie. That's what I was trying to do."
Marc Pouliot, Ales Hemsky and Sam Gagner each tried to get Edmonton (14-14-3) even, only to see Hiller add three more saves to snap a personal four-game losing streak.
"Unbelievable," Perry said. "He's the reason we won the game."
Jean-Sebastien Giguere, who missed the game in order to attend a memorial service for his father, Claude, in Montreal, and former Ducks goalie Mikhail Shtalenkov also hold a piece of the single-game club record for saves. Giguere had 51 in an 8-6 victory over the visiting Detroit Red Wings on March 21, 2004. Shtalenkov's 51 stops came March 22, 1998 in a 5-2, road triumph over the Ottawa Senators. … Ducks winger Todd Marchant appeared in his 999th career game. … The victory was only the third by the Ducks in their past 17 regular-season visits to Edmonton.
1. JONAS HILLER: Ducks goalie tied a single-game franchise record with 51 saves, and added three more in the shootout
2. COREY PERRY: Ducks right wing scored on the power play in the second period and came through with the lone shootout conversion
3. SHELDON SOURAY: Edmonton defenseman with the big shot fired off a game-high 11


text:
Support us
About & contact
Norfolk Wildlife Services
Join now
Wildlife in Norfolk
Wildlife in Norfolk
Nature reserves
Species explorer
Habitat explorer
Wildlife information service
Wildlife calendar
Discover wildlife in Norfolk
Wildlife surveys
Ranworth Webcam
Roadside Nature Reserves
Reserve Facilities
Visitor Centre
Boat trips
Bird watching hides
Nature Trails
Groups welcome
Cley Marshes
Ranworth Broad
Discover Woodlands
Marsh Harrier
Swallowtail butterfly
Wildlife Information Service
Wildlife in January
View all
The Wildlife Information Service is here to give advice and answer any questions you may have about Norfolk's wildlife.
Do you have a question about Norfolk's wildlife?
A Living Landscape
A Living Landscape
My Living Landscape
County Wildlife Action
Where to go
Wildlife advice
Seasons explorer
County Wildlife Sites
Churchyard Conservation Scheme
Act for Nature
Wildlife sightings
Living Landscapes
Bure Valley
Cley to Salthouse
Gaywood Valley
North Norfolk Woods
Upper Thurne
Living Seas
Bure Valley in winter
Gaywood Valley in winter
Wissey Valley
Cley to Salthouse in winter
County Wildlife Sites
Take action
View all
Discover, Explore, Take Action in your Living Landscape
My Living Landscape
All News
Cley Calling – Autumn Colours
Wed 20 Sep, 2017
Celebrating two decades of rubbish help for biodiversity
Tue 19 Sep, 2017
Investing in the future – NWT's apprenticeship programme
Thu 14 Sep, 2017
Living Landscapes
Living Seas
Wider Conservation
View all
View all
Latest news stories about our work, activities and events.
All the latest news from NWT
All photos
Images we need
Submit a photo
A Living Landscape
Amphibians & reptiles
Marine & Seashore
View all
View all
We are on the hunt for images of particular species in Norfolk... have you managed to snap one?
Have you seen...?
What's on
What's on
All Events
Cley Calling
Fungus foray
Sun 24 Sep, 2017
Yoga for health
Mon 25 Sep, 2017
A World Of Raptors
Mon 25 Sep, 2017
A Living Landscape
Living Seas
Local Groups
Art and Nature
View all
View all
Come and discover wildlife as a family! Every event is enjoyable for all ages, making them a wonderful way for families to explore the natural world together.
Events taking place for all the family to enjoy
Discover & Learn
Discover & Learn
Families and children
Adult learning
National Marine Week
Simon Aspinall Wildlife Education Centre
30 Days Wild
Every Child Wild
Simon Aspinall Centre
Fantastic new events programme
Exhibitions at Cley
Family events at Cley
Talks at Cley Marshes
Workshops at Cley Marshes
School visits to our reserves
Wildlife Watch
School sessions
Explore our visitor centres
My Wild Winter
Explore wildlife at home
Explore the shore
Find out more
Six visitor centres around Norfolk, getting you closer to wildlife
Visitor Centres
Join now
Corporate membership
Local groups
Membership magazines
Terms and Conditions
Together we can save Norfolk's wildlife - become a member today
From the wild north coast to the sandy heaths of Breckland, the Norfolk Broads to ancient woodlands, Norfolk's diverse habitats are home to a stunning variety of wildlife. Joining us today makes a real difference to Norfolk. Your support helps us protect the future of that wildlife and helps us inspire people to value nature.
Find out more
Join or renew today
More ways you can support us
Other ways to support us
Search site
Share this page
Google Plus
← All News
All News
2016-12-06 A strong step towards securing
News article
All News
Top News
Cley Calling – Autumn Colours
20 Sep, 2017
This autumn, you can explore North Norfolk'...
Celebrating two decades of rubbish help for biodiversity
19 Sep, 2017
It feels counterintuitive - the waste we produce hel...
More ways you can support us
Other ways to support us
Social media
Common Crane by David Tipling
A strong step towards securing Hickling Broad
Tuesday 06 December, 2016
Norfolk Wildlife Trust has announced that over £128,000 has been donated so far as a result of it launching the Hickling Broad Land Purchase appeal to raise £1 million by March 2017.
In response to a call to its 35,000 members, local businesses and charitable trusts, this amount has already been received at the end of the first official week of the appeal.
The appeal was formally launched on 18 November with all NWT members written to seeking their support. Donations have been coming in from far and wide, with people expressing their wishes that Hickling Broad will be protected long into the future.
655 acres of the Hickling Broad Estate were put on the open market in September. Norfolk Wildlife Trust reached agreement to buy the land which makes up almost half of its National Nature Reserve for £2.5 million. While funding of £1.5 million has already been secured, NWT needs a further £1 million to purchase this nationally and internationally important wetland for wildlife.
Whilst the National Nature Reserve has been in NWT's care since 1945, it does not own it in its entirety and this purchase will allow the Trust to unify the reserve (1400 acres) under its ownership.
Head of Development Nik Khandpur said, "We know we are up against a tight time frame in which to achieve the largest and most expensive single land purchase in the Trust's history. The response in the first week has been incredible and we are moved by how many of our members and the public have been in touch so quickly to help us secure this exceptional nature reserve. However, we know it is very early days and that we have almost 90% of the £1 million still to raise."
Chief Executive, Brendan Joyce said, "The purchase is recognised by the Trust as being an historic achievement and it would be a fitting legacy to our 90th celebrations. There is no doubt in our minds that this is a national jewel and if we secure it now we will be protecting its rare and endangered wildlife and also making the best of the Broad for all the people who love it and use it."
More than 1,400 acres of reedbed, fen, grazing marsh, open water and woodland make up the Hickling Broad National Nature Reserve that also has national and international conservation designations.
Its wetland habitats, sensitively restored by Norfolk Wildlife Trust, offer a year-round haven for threatened wildlife such as iconic swallowtail butterflies, marsh harriers, Norfolk hawker dragonflies, the common crane and of course, the bittern.
To donate to the Hickling Broad land purchase appeal you can donate by visiting our website at:
or on our Just Giving page:
or telephone: 01603 625540
- Ends –
Living Landscapes
Wider Conservation
Share this
Top news stories
Cley Calling – Autumn Colours
Wednesday 20 September, 2017
This autumn, you can explore North Norfolk's colourful coastal landscape and culture as part of NWT's ...
Celebrating two decades of rubbish help for biodiversity
Tuesday 19 September, 2017
It feels counterintuitive - the waste we produce helping to restore habitats and conserve some of Norfolk's mos...
Investing in the future – NWT's apprenticeship programme
Thursday 14 September, 2017
Nearly three years ago, thanks to support from Lincs Wind Farm, Norfolk Wildlife Trust appointed two apprentices to u...
Breeding redshank return to Roydon Common after 40 years
Monday 11 September, 2017
A new noise has joined the cacophony of bubbling curlew, drumming snipe and the 'tooo-wips' of lapwing th...
Theft of the food plant and caterpillars of the rare swallowtail butterfly from internationally important nature reserve
Tuesday 18 July, 2017
Norfolk Wildlife Trust has reported the uprooting and theft of five milk parsley plants from its nature reserve at Hi...
Norfolk's magical meadows
Tuesday 27 June, 2017
Norfolk Wildlife Trust is leading a free meadow tour of Mulbarton Common this Saturday 1 July 2017 as part of The ...
Wildlife champion receives Queen's birthday honours
Saturday 17 June, 2017
Norfolk Wildlife Trust is delighted to announce that its Chief Executive, Brendan Joyce, has been awarded an OBE in t...
From Dartmoor to Breckland
Wednesday 07 June, 2017
New ponies settle in to manage Cranwich Camp, Norfolk. Sixteen Dartmoor Ponies are settling in to their new...
New poll reveals that Norwich's city-dwellers love nature but don't get enough of it
Thursday 01 June, 2017
30 Days Wild challenge from Norfolk Wildlife Trust helps people enjoy nature every day A new poll of 101 people l...
Volunteer taster day at NWT Holme Dunes
Wednesday 24 May, 2017
Interested in volunteering but not sure it's for you? Then come and join us at our Taster Day at Holme Dunes...
Bird Photographer of the Year at NWT Cley Marshes
Thursday 11 May, 2017
From Monday 15 May Norfolk Wildlife Trust will be hosting the Bird Photographer of the Year exhibition at its NWT Cle...
Cley Calling - Spring Song
Wednesday 03 May, 2017
Musicians and artists celebrate spring at the North Norfolk Coast From Thursday 4 May to Sunday 7 May, Norfolk Wi...
Hide footer
Make a donation
Volunteer & Jobs
What's on
Head Office
Norfolk Wildlife Trust
Bewick House
22 Thorpe Road
Norwich, NR1 1RY
About and contact
Privacy policy
Terms of use
Social Media
NWT Blog
Popular resources
A Living Landscape
Nature reserves
Species explorer
Habitat explorer
© 2017 NWT Reg Charity Number 208734
+44 (0) 1603 625540
Top of page
Empresa web design


text:
Fire Damage Restoration
Do You Have Fire Damage?
Need Help Now?
24 Hour Service
Immediate Response Team
Emergency Fire Damage Restoration
We Work With All Insurance Companies
We File Your Claim For You
Do You Think You Have Mold?
Mold Testing
Mold Inspections
Mold Remediation & Repair
We Work With All Insurance Companies
We File Your Claim For You
Mold Damage Restoration
Water Damage Restoration
House Flooded?
Need Help Now!
24 Hour Emergency Service
Immediate Response Team
Water Extraction, Removal & Restoration
We Work With All Insurance Companies
We File Your Claim For You
Water & Flood Restoration
Fire & Smoke Restoration
Mold Inspections & Remediation
Storm Damage Restoration
Storms can happen at any time and our team is available 24 hours a day to help restore your home or business after a major storm in Tucson. Call the Action 1 Restoration of Tucson team today!
Action 1 Restoration of Tucson provides emergency water damage, mold removal, storm damage and fire restoration services in the Tucson, Az Valley. Our team has the experience, equipment and knowledge to help you with all your disaster restoration needs.The company we work with in the Tucson area is IICRC certified, part of the BBB and a registered member of the ROC. They are certified in both commercial and residential water and fire damage restoration services. 24 hours a day 7 days a week, the Action 1 Restoration of Tucson team is here to help you. If you are faced with a large loss or small loss, we are here to help you get your home or commercial building restored and back to normal.
We work with your insurance company and provide insurance deductible assistance programs. We are insurance specialists and we bill your insurance company directly for our services.
Generally our team can be at your home within one hour from the time you call us. We are building a large network of local offices across the country in order to provide our clients the best services possible, no matter where they call from, no matter what time of day it is. Our team realizes these disasters can happen at any time and usually happen at the worst times possible. When you call us, you will know right away that you made a good decision by calling the Action 1 Restoration of Tucson Team. Read a brief overview about our restoration services here.
Action 1 Restoration Corporate Site – http://www.action1restoration.net/
Restoration Services – action1restoration.net/restoration-services/
Water Damage Services – http://www.action1restoration.net/water-damage/
Water Tips
Water repair and cleanup tips will be coming soon to help you!
Fire Tips
Fire cleanup and repair tips that can help you after a fire is coming soon!
Sewage Tips
Sewage cleanup and repair tips that will be able to help you are coming soon!
Smoke & Soot
Smoke and soot cleanup tips coming soon!


text:
It only takes a minute to get started. Fill out our simple sign up form and login to the website.
This step is up to you but will greatly enhance your chances of getting noticed by other people on the site. Write about yourself, your interests and upload some good photographs of yourself.
Use our website's state-of-the-art search to find members who suit your needs. Or just look through listings and find daters that pique your interest.
Found someone who ticks all the boxes? Send a letter to them or just a wink and let it develop from there. With a little luck you'll be on your way to a lifetime of happiness.
And start dating


text:
Vadim Nasardinov wrote: > I assume you're talking about > org/postgresql/jdbc2/AbstractJdbc2Statement.java which has this piece > of code (slightly reformatted to fit on a 80-column page): [snip] > This does appear to be optimized for reading smallish chunks of text. > If the character source behind the Reader is sufficiently large, I > believe we'd be better off building up a StringBuffer rather than a > character array. Something like this: > > if (connection.haveMinimumCompatibleVersion("7.2")) { > StringBuffer sb = new StringBuffer(length); > BufferedReader br = new BufferedReader(x); > try { > while(true) { > String chunk = br.readLine(); > if (chunk == null) { break; } > else {sb.append(chunk); } > } > } catch (IOException l_ioe) { > throw new PSQLException(GT.tr("Provided Reader failed."), > PSQLState.UNEXPECTED_ERROR, l_ioe); > } > setString(i, sb.toString()); > } > > The reason this is better is because > > (a) the String(char[],int,int) constructor always defensively copies > the passed in character array. So, as you point out, if you > pass in a 10-million-character array, a new 10-million character > array will be allocated. > > (b) in contrast, if you construct a String from a StringBuffer, they > can share the underlying character array: > http://www.google.com/search?q=Heinz+Kabutz+StringBuffer+Issue+068&btnI This is indeed part of the code I was talking about. And indeed a StringBuffer is already a definate improvement. However, the setString() method will also cause the data to be duplicated when escapeString() is called. A version of escapeString() which works on a StringBuffer would be another improvement in my opinion, saving (if the allocated StringBuffer is made a bit larger to allow for the escaping), in most cases another allocation of the whole string. Greetings, Sebastiaan van Erk
Next: From: Alan Stange Date: 2004-11-02 16:04:53 Subject: executeBatch() issue with new driver? Previous: From: Vadim Nasardinov Date: 2004-11-02 14:46:09 Subject: Re: ps.setCharacterStream() and memory usage


text:
Live Oak marijuana dispensary burglarized
Burglars smashed a glass door and took about $3,000 worth of marijuana and marijuana products from Granny Purps medical marijuana dispensary on Sunday night.
About 10:20 p.m., four suspects who wore masks and hooded sweatshirts got out of a dark sedan near the store at 2649 41st Ave., said Santa Cruz County sheriff's deputy April Skalland.
A video surveillance camera showed the burglars throw river rocks through a glass door, kick the glass out and enter the shop. An alarm sounded, and they grabbed items from the front lobby area and fled in the car, Skalland said.
Deputies responded minutes later in part because of the alarm. No one has been apprehended.
Deputies have not released descriptions of the burglars, who also wore gloves.
The marijuana dispensary had been burglarized before.
On June 3, 2011, several men also smashed its glass door with rocks and collected more than $6,000 worth of marijuana in the heist.
The Santa Cruz County Sheriff's Office asks anyone with information to call the investigations division at 831-454-2311 or the anonymous tipline at 831-454-5995.
Deputies seek man who pointed gun at resident, stole SUV
Deputies tried to find a man who broke into two homes and stole a Ford Explorer in the Soquel Hills on Tuesday.
In the early afternoon, a resident returned to his home on North Rodeo Gulch Road and saw a burglar inside, said Santa Cruz County sheriff's deputy April Skalland.
He chased the burglar, who had a gun or a toy gun, authorities said.
As the burglar fled in a silver Lexus, the man smashed some of its windows. The resident relayed the license plate number to authorities, but it was a California exempt plate that was stolen, Skalland said.
Deputies and California Highway Patrol officers surrounded the area and issued a Project Rope, which described the man as white and about 5 feet 5 inches tall, Skalland said. He wore a sports team jacket, but there was no further description.
Project ROPE was called off about 1:55 p.m., according to emergency dispatches.
About that time, another resident on Hall Ranch Road arrived home and found the silver Lexus parked near the home. The resident's blue 1997 Ford Explorer was stolen from the garage.
Its license plate number is 3TIC192.
Deputies tried to find the Ford on Tuesday and have not said whether anything was taken from the homes.
The Santa Cruz County Sheriff's Office asks anyone with information to call dispatch at 831-471-1121, the investigations division at 831-454-2311 or the anonymous tipline at 831-454-5995.


text:
70's Themed Cake (Or Groovy Cake)
I did this for a friend's birthday. They wanted a 70's themed cake. I used the new Crisco for the buttercream and for the first time in years I couldn't get the icing to act right! It just wouldn't smooth and take the color but it was too late to start over!
It's buttercream and everything else is made from fondant.


text:
- « first
- ‹ previous
- 1
- 2
- 3
Congratulations, LM! I really enjoy this game but have nowhere near your dedication to it. I completed about 6 stories and at least a handful of the animals. I think it just barely misses my GOTY list. It's great in its simplicity, giving it that arcade feel. At the same time, I wish they'd done more with the mechanics so that the only differentiation wasn't just a procedurally generated world and slight changes to the way animals play. It sounds like it was successful in Japan and the US, so I hope they get a chance to improve upon what is already a compelling and fun survival action game.
Now I can focus on powering up my ostrich. I love this game. :D
I've not played in a while. I don't yet have my ostrich to kick dinosaurs in the face. Can you raise the base stats of animals? Something along the lines of having your attack go from a starting point of 4 to 5 every time you start a new game with that animal.
Not crazy about how expensive items are, either, especially given their low durability. I mean, if you're wearing footwear you essentially can't attack, and the better items cost all the profits from a good run to replace. I typically end up using the indestructible DLC items or nothing at all.
That sucks, it was one of the things I'd figured would get better as you progress. Glad I picked it up on launch. Hell, I got it with a discount, so I easily got my monies worth.
So it's a prequel, right?
I finally got to be an ostrich and kick a dinosaur in the face today!
Is there any secret for finding the bosses (the last challenge for the animals)? I know it lists the area, but I've had a tough time finding a couple of them in those areas.
Yes- very, very, very, very, very, very worth it. Also, it's weird.
On sale for 99 cents this weekend. I assume it's worth it?
My wife and I still go back to that game, and we bought it for 12$.
It is worth it.
Currently $0.90 on the Playstation store. Lasts till 2015/03/23.
- « first
- ‹ previous
- 1
- 2
- 3


text:
From a Humboldt County Sheriff's Office press release:
On Monday, at approximately 2:30 p.m. a citizen came to the Sheriff's Office and reported her son, Tracy Edward Johnson, 39 years old, was in possession of illegal weapons. The citizen said Johnson was staying at her residence in the 2400 block of Eel River Drive, Loleta. The citizen told the investigating deputy he showed up at her home approximately two weeks earlier with what appeared to be assault weapons and pistols. The citizen told the deputy that Johnson had a history of violence, just got off parole, and was not allowed to legally possess firearms. She added she was afraid Johnson would use the weapons against law enforcement if he knew law enforcement was coming for the weapons. The citizen gave the deputies consent to search her residence.
On Monday, at approximately 3:30 p.m., deputies drove to the citizen's residence and knocked on the door. Johnson, who was home alone, answered the door and then attempted to close it on the deputies. As deputies entered the residence, Johnson moved towards a couch which was a few feet away. Deputies detained Johnson in handcuffs for their safety. Deputies located two loaded stolen rifles behind the couch and a loaded stolen semi auto handgun under the seat cushion of the couch.
Deputies learned the weapons were stolen from a locked vehicle in the 2300 block of Bongio Court, Eureka between Feb. 13 and Feb. 22. H.C.S.O . Case 201400862. Deputies located additional stolen property in the residence, along with pepper spray and syringes. Johnson was arrested for being a convicted felon in possession of a firearm, being a convicted felon in possession of a loaded stolen firearm, criminal storage of a firearm, illegal possession of an assault weapon, being a felon in possession of ammunition, grant theft, possession of stolen property and being a felon in possession of tear gas. He was transported and booked into the Humboldt County Correctional Facility where his bail was set at $50,000.
Anyone with information for the Sheriff's Office regarding this case or related criminal activity is encouraged to call the Sheriffs Office at 707-445-7251 or the Sheriffs Office Crime Tip line at 707-268-2539


text:
TokyLabs – YoMoBot – Friday @11
Friday, 30 Jun 2017
11:00 - 11:45
Build and programme your very own light activitated YoMo monster robot complete with very own polymorphic plastic shell that can be moulded by hand to create unique deisgns for each robot.
In this edition we prepared Tokybot so it can detect light intensity! The light sensor assists in helping your robot to "see." It enables your robot to distinguish between light and dark, as well as determine the light intensity in a room. You can use this capability to control it directly in realtime using a source of light.This fun robotics curriculum starts out with this YoMo workshop. With the help of instructors you will develop mechanichal, electronics and programming skills, teaching you how the sensors can be used to control the robots and encourage you to go further on tinkering with the technology. After the assembly of Tokybot, the students can use it as an engaging tool for design thinking activities, gamification and team management activities.


text:
I have had a most unnerving experience this week. For the first time in my life I have experienced jaw-clenching pressure. I thought I had experienced the true meaning of pressure during my undergraduate finals. But I realised I was wrong when I encountered real pressure near the end of my Ph.D., when all I had was 6 weeks to finish all the lab work. But again, there was another dimension to pressure I still had to probe. Recently, I have met the real McCoy and it left me physically short of breath. It was the kind of pressure that leaves you shaking inside, even though you try all the relaxation tricks you know.
So what plunged your old friend Phil into this cul-de-sac of stress? Being as open and honest as ever, I will naturally tell you. But first be reassured that I've already managed to reverse out of "stress alley." It was not a nice place to be. In recent years the "stress screw" has been turned more tightly in all professions. Everyone now has targets and deadlines, and we all have our own personal league table to try to clamber up. Coupled with this, job security by and large doesn't exist anymore. OK, that's enough bleakness. You don't read this column to top up on depressive stories. You want advice to encourage and uplift you, so let me perform a little analysis of what I went through.
The truth is, I'm not 100% certain why I let myself get in such a state to start with. But stress is like that; it slowly creeps up on you unannounced and then one day grabs you from behind. We all have a threshold beyond which we freak. We see stress as the enemy, but it may just be a safety valve that warns us when to stop before we hit serious trouble. I, for one, am glad that my threshold is set no higher than it is. This has been an extraordinarily busy time for me, both in and out of work. My social life and voluntary work are both piled high, whilst at work things have never been more frantic.
This week alone I have been trying to get a paper out, write a review, and move forward with my back-to-back grant and fellowship applications. This is on top of routine stuff such as presenting my work at a seminar, supervising a postgraduate student in the lab, whilst going ahead full throttle with my own experiments, not to mention a dozen or so minor inconveniences like several assorted meetings to attend. It is utterly insane. If I were working this hard in advertising, I would have my own team of people and an annual salary far beyond what I'm likely to earn in the next 4 or 5 years put together.
The point is that we postdocs are particularly vulnerable when it comes to stress. I know some principal investigators reading this will argue that "You ain't seen nothing yet," but I plead extenuating circumstances on three counts. Firstly, in real terms, you guys have already made it: You've been rated highly enough to get a proper job. So, even though the pressure's still on you to perform, the pressure to find your own salary every 3 years is now off. I have a sneaking feeling that a little more security about what on earth all this effort is for would have gone a long way to chilling me out recently.
Secondly, you PIs are used to stress and we postdocs are not. What I experienced was pure culture shock. My mind and body had never taken this kind of punishment before. At the height of my stress I just wanted to be a student again--at least for a week or two's convalescence. Thirdly, we postdocs have to be full-time experimental scientists on days when we could easily spend 10 hours in front of our computers just like proper PIs.
For me, there is only one way to do a stress reverser. I find that just trying to relax and ignore it all is impossible. The stress comes to get me at night when I am asleep and I wake up, heart pumping. The way I see it, I either have to quit my career or crack on with it. As the former isn't on my list of options, I'd better face up to the latter. The work isn't going to disappear unless I set about making it go away. So, my solution is twofold.
First, you need to work very hard. Second, you need to survive the onslaught of all this work. Avoid the danger of burning out by first throwing overboard anything and everything you possibly can. Focus solely on urgent, essential tasks. When faced with a seemingly infinite amount of work but a definitely finite amount of time, you have to cut corners where you can. Push on to complete individual tasks rather than spinning plates, because task completion equals your stress level coming down a notch or two. Next, treat yourself to an easier life for the duration of your struggle. Eat out. Get to bed early and sleep yourself silly. Plan your summer holiday. Just do anything that reminds you that there is a lot to enjoy out there and better times to look forward to.
A wise person once said to me, "All things come to an end." Eventually the once impossible becomes possible. You will find yourself in calmer waters reflecting with a wry smile on that crazy time back in the spring when you wondered why on earth you ever went into science. I reckon all this stress is some bizarre rite of passage organised by all PIs everywhere to see if we postdocs have what it takes to make it to the top. I say, fellow postdocs, don't let them see you beaten. Let's push on to the finishing post!


text:
A group suing over Anschutz Entertainment Group's proposed NFL stadium wants the developer to pay roughly $60 million for affordable housing in the downtown area.
The Los Angeles Community Action Network wants AEG to fund a $2 million-a-year housing trust for the life of the stadium, which is seen as about 30 years, LACAN co-director Becky Dennison said Thursday.
LACAN is a member of Play Fair at Farmers Field, a coalition of downtown affordable housing and environmental groups that filed a lawsuit last month against the state over legislation that fast-tracks legal challenges on the stadium's environmental analysis.
The group also includes the Legal Aid Foundation of Los Angeles.
The coalition has a number of issues, including air quality concerns and transit worries, Dennison said. But affordable housing is a main sticking point.
Believing rents could rise around the stadium, and that parking lots will replace affordable housing buildings around downtown, LACAN wants AEG to create a housing fund, Dennison said in a brief interview Thursday.
Negotiations between AEG and Play Fair at Farmers Field are continuing, Dennison said, with the two groups involved in weeks of recent mediation talks.
"We are very open to further mediations," Dennison said. ""We have made that very clear."
Ted Fikre, AEG's chief legal and development officer, said the $60 million figure is "significantly higher" than previous amounts sought by the coalition. At the start of negotiations, the coalition asked for $10 million from AEG, he said. Later, the coalition indicated it wanted $20 million. Fikre was unaware of LACAN's new demands until told by the Daily News on Thursday.
The stadium doesn't displace residents, so AEG shouldn't have to pay for a housing trust, Fikre said. Nevertheless, he said, negotiations would continue with the coalition.
Concessions on AEG's part could encourage LACAN and others to drop their lawsuit over the stadium.
Meanwhile, backers of the stadium are growing more vocal in their concern about the Play Fair at Farmers Field lawsuit.
The litigation "could take down the project," David Pettit, senior attorney for the Natural Resources Defense Council, warned City Council members on Thursday.
Pettit, who believes the downtown stadium represents an important infill project, urged City Councilwoman Jan Perry to "lock AEG and LACAN and the Legal Aid Foundation of Los Angeles in a room" until a deal is negotiated to allow the stadium to go forward.
While filed against the state, and not the city or AEG, the lawsuit could delay AEG's ability to lure an NFL team to the area since the league is wary of signing a deal with a developer if there is any litigation over the stadium.


text:
Status: Committed to Perrie Edwards
Born: Bradford, England
Birthday: January 12, 1993
Who is he?
Nineteen-year-old, Zayn Javvad Malik is one of the members of the four-piece band One Direction. This half-Brit, half Pakistani bloke got his first break in the seventh season of "The X Factor". He bagged the respect of all three judges — Simon Cowell, Nicole Scherzinger and Louis Walsh — with his performance on "Let Me Love You" by Mario.
Why he is droolworthy
He is the sweet, talented boy you want to bump into on your first day of college. He has the potential to be that frat boy with a heart who every chick wants to go to the prom with.
We want to put his interview on replay because, let's all admit it, no woman can resist a man with an English accent. Actors like Colin Firth and Hugh Grant are seasons past their shelf life but we are still holding on to them because of that dreamy accent. Zayn's wolfy eyebrows and his Jimmy Neutron hair are proof enough that he will never disappoint us as far as making a fashion statement is concerned. Apparently it's this Paki-Brit's hairdo that makes Miley Cyrus go ga ga for him. Miley totally eyes Zayn and doesn't mind cyber-flirting with him. "We've spent an hour stalking Zayn from @onedirection," she tweeted. Zayn himself is open to public displays of attraction and mocks those who seem too guarded about it. "Clearly some people are not very familiar with flirting :)," he tweets.
But Zayn is not just eye candy and wins extra brownie points for showing off his love of reading on Twtitter.
He credits his girlfriend Perrie for building his confidence. Zayn says, "Yes, I'm a big believer in the motto, 'Behind every great man there's a great woman'. And she's great." That is the most endearing admission of a woman's influence we have heard in a long time.
What you didn't know about him
He got nervous at his auditions for "The X Factor" and decided to remain backstage, effectively running the risk of elimination. Simon Cowell noticed Zayn's absence, went backstage and convinced him to return. We can't be more proud of this goodlooking desi-gora mix for impressing music mogul Simon. Everytime he sings "You Know You're Beautiful" we believe it!
Published in The Express Tribune, Ms T, December 2nd, 2012.
Like MsT on Facebook and follow at @TribmagMsT for your dose of girl talk